Bone targeted treatments in cancer - The story so far.

J Bone Oncol · 2016 · PMC5063216 · PMID 27761363

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

highly significantno p-value reported

There were no demonstrable benefits in premenopausal women but in 11,767 postmenopausal women, highly significant reductions in bone recurrence (RR=0.72; 95%CI 0.60–0.86, 2p=0.0002) and breast cancer mortality (0.82; 95%CI 0.73–0.93, 2p=0.002) were seen.

also in 132,142 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.